EUVIMEDEUVIMED entdecken
Crossref

Centralized monitoring for diversion prevention decreases controlled substance variances

Michael Van Ornum, Melissa Wilson

Journal of the American Pharmacists Association · 2025-09 · 65 (5) · 102426

DOI: 10.1016/j.japh.2025.102426 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Pharmacists Association, 2025-09. Verfasst von Michael Van Ornum und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Controlled Substances, Prescription Drug Diversion, Pharmacy Service, Hospital. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Controlled substance (CS) stewardship is essential for regulatory compliance, mitigating diversion, and supporting patient safety. The development of a comprehensive CS diversion prevention program (CSDPP) is resource intensive and may take years to mature. OBJECTIVE: We rapidly address CS variances through monitoring as an initial step toward comprehensive CSDPP development. PRACTICE DESCRIPTION: Diversion management software (DMS) was used for 2 years across the twelve acute care facilities of the integrated delivery network before implementation of the centralized team. During this time, inconsistent practices in reconciling CS variances created a backlog of 28,000 unreconciled variances in 2023. PRACTICE INNOVATION: We created a cost-efficient centralized multidisciplinary team as the first step of developing a CSDPP to rapidly and efficiently monitor CS variances and through that monitoring, strengthen regulatory compliance while promoting CS stewardship practices. EVALUATION METHODS: We compared early data from the DMS with later data to evaluate apparent loss variances and accountability of drug disposition. Computer-based training provided education completion metrics. Pharmacy leaders reported regulatory agency contacts for 2023 which was compared with recorded contacts in 2024. RESULTS: Centralized, daily review of CS variances resulted in 100% review of all variant CS transactions within 3 months of team creation. CS stewardship improved. After 1 year, apparent loss variances decreased by 41%, accountability for drug disposition improved from 62% to 93%, and regulatory reporting decreased 41%. CONCLUSION: Improving the monitoring portion of a CSDPP realized significant benefits within 6 months which extended and improved over a year: a significant reduction in apparent loss variances, enhanced regulatory compliance, and improved regulatory reporting. This initial foundation of centralized monitoring captured critical incremental benefits while establishing a structure within which to grow and expand the CSDPP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Controlled SubstancesPrescription Drug DiversionPharmacy Service, HospitalHumansPharmacistsSoftwarePatient Safety

Substanzen

Controlled Substances

Zitieren

APA

Van Ornum, M., & Wilson, M. (2025). Centralized monitoring for diversion prevention decreases controlled substance variances. Journal of the American Pharmacists Association, 65(5), 102426. https://doi.org/10.1016/j.japh.2025.102426

Vancouver

Van Ornum M, Wilson M. Centralized monitoring for diversion prevention decreases controlled substance variances. Journal of the American Pharmacists Association. 2025;65(5):102426. doi:10.1016/j.japh.2025.102426

BibTeX
@article{VanOrnum2025,
  author = {Van Ornum, Michael and Wilson, Melissa},
  title = {Centralized monitoring for diversion prevention decreases controlled substance variances},
  journal = {Journal of the American Pharmacists Association},
  year = {2025},
  volume = {65},
  number = {5},
  pages = {102426},
  doi = {10.1016/j.japh.2025.102426}
}
Kostenlos starten →